Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a reduced-toxicity myeloablative conditioning regimen for cord blood transplantation in pediatric p…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: In-Vivo Activated T-Cell Depletion to Prevent GVHD [NA]
Indiana University conducted a terminated clinical trial evaluating in-vivo activated T-cell depletion to prevent graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS) [Phase 2]
Pfizer's axitinib (AG-013736) was studied in a Phase 2 trial in patients with poor-prognosis acute myeloid leukemia or myelodysplastic syndr…
-
CLINICAL_TRIALS research · 2012-03-16Clinical Trial Update: The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). [Phase 2]
A Phase 2 trial is evaluating the efficacy of azacitidine with or without lenalidomide in high-risk myelodysplastic syndrome and acute myelo…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-03-06Clinical Trial Update: Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia [NA]
This clinical trial update describes an individualized exercise program for patients undergoing chemotherapy for newly diagnosed or relapsed…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) [Phase 1]
This Phase 1 trial of the DT388GMCSF fusion protein in acute myeloid leukemia and chronic myelomonocytic leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Phase 1, Phase 2]
Dose-escalation study of clofarabine in combination with cytarabine and idarubicin as induction therapy for high-risk acute myeloid leukemia…
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia [Phase 2]
This document provides an update on an extension study of tosedostat for relapsed/refractory acute myeloid leukemia (Phase 2). The current s…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML) [Phase 2]
Phase 2 study evaluating a home-based exercise program for patients with acute myeloid leukemia has completed, according to the trial update…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating sirolimus plus tacrolimus for graft-versus-host disease prophylaxis after related stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Use of the MiCK Assay for Apoptosis in AML
An update on a clinical trial evaluating the MiCK assay for apoptosis in acute myeloid leukemia. The document summarizes the trial status an…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [Phase 2]
A Phase 2 study evaluating sirolimus with tacrolimus for graft-versus-host disease prophylaxis after unrelated donor stem cell transplantati…
-
FDA approval · 2012-01-24FDA Approved: VIDAZA — Supplemental Application (Celgene Corporation)
The FDA approved a supplemental application for Vidaza (azacitidine) submitted by Celgene Corporation.
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 safety study evaluating the combination of azacitidine with donor lymphocyte infusion for relapsed acute myeloid leukemia or myelody…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP [Phase 1, Phase 2]
This clinical trial update reports Phase 1/Phase 2 results for the combination of PTK 787 and imatinib (Gleevec) in patients with acute myel…
-
CLINICAL_TRIALS research · 2012-01-20Clinical Trial Update: Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of a recombinant WT1 antigen-specific cancer immunotherapy combined with i…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Phase II Study of Maintenance With Azacitidine in MDS Patients [Phase 2]
Phase II study evaluating maintenance azacitidine in patients with myelodysplastic syndromes and acute myeloid leukemia; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia [Phase 1]
This Phase 1 safety study of MultiStem in patients with acute myeloid leukemia, chronic myeloid leukemia, or myelodysplastic syndromes has c…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Prospective Database for Acute Myeloblastic Leukemia [NA]
A prospective database study for acute myeloid leukemia is listed, sponsored by King Faisal Specialist Hospital & Research Center. Phase and…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating the combination of gemtuzumab ozogamicin and cyclosporine in older patients with relapsed acute myeloid leukemia ha…
-
FDA approval · 2011-11-22FDA Approved: IDARUBICIN HYDROCHLORIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved a supplemental application for idarubicin hydrochloride from Meitheal Pharmaceuticals Inc., authorizing a generic version u…
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation [NA]
This clinical trial evaluated busulfan monotherapy as conditioning for autologous hematopoietic progenitor cell transplantation in acute mye…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Trial of Decitabine in Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update for decitabine in acute myeloid leukemia; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) [Phase 3]
Phase 3 CLASSIC I trial evaluating clofarabine in combination with cytarabine for older patients with relapsed or refractory acute myeloid l…